April 7, 2016—Drug manufacturers more than doubled the price of insulin – which people with Type 1 diabetes need to stay alive – between 2002 and 2013, according to new research published in JAMA.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)